- Conditions We Treat
- Support Services
- Find a Consultant
- About CCL
- Contact Us
QualificationsMBBS MSc PhD
Dr Yong Du graduated from Shandong Medical University. He was awarded a PhD in Cancer Sciences at University of Southampton for his work on lymphoma and completed his nuclear medicine specialist training at the Institute of Nuclear Medicine, University College Hospital in London. He was the first recipient of the national HEFCE Clinical Senior Lectureship Award in the Nuclear Medicine speciality (awarded in June 2009).
In conjunction with his clinical practice, he has research interests to further assess the role, efficacy and limitations of PET/CT in various cancers, so as to optimise its use and inform tailored treatments for individual patients. Dr Yong Du also has extensive experience in radionuclide targeted therapy. He is interested in combining the fast advancing functional imaging technology with multidisciplinary expertise to help develop and optimise radionuclide targeted therapy for cancer patients.
Dr Young Du has led a number of national and international research projects and has published first-authored research articles in high impact oncology journals including the Journal of Clinical Oncology, Blood, Cancer Research, etc. He has been leading the radionuclide therapy services at the Christie Hospital and the Royal Marsden Hospital, the biggest cancer centres in the UK since May 2009. Dr Yong Du has treated the largest number of patients with Lutetiun-177-PSMA in UK.
Dr Yong Du is a Trustee of the British Nuclear Medicine Society. He was the first recipient of the UK HEFCE Clinical Senior Lectureship award in the Nuclear Medicine speciality. He lectures in national and international medical conferences regularly.
Please note these are regular clinics, other times may be available by appointment
Contact us on:020 8247 3351